Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion


Phase 3 Results N/A

Summary of Purpose

The purpose of the present, randomized, controlled multicenter phase III trial is to investigate the safety and efficacy of continuous 1-hour insonation of occluded middle cerebral artery with 2 MHz TCCS in stroke patients treated with intravenous tissue plasminogen activator (t-PA) within 3 hours after symptom onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 April 2007.

1 Jun 2006 13 Jun 2006 Unavailable 1 Jun 2009 1 Apr 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment